In the News

Search In the News
Search by date
Choose From Date
Choose To Date
SearchClear

"Fed. Circ. Deals Blow To Takeda In Prevacid Battle"

January 22, 2010
IP Law 360

On January 22, 2010, the U.S. Court of Appeals for the Federal Circuit affirmed the U.S. District Court for the District of Delaware decision that Takeda Pharmaceutical Co. Ltd. did not prove infringement in its case against Teva Pharmaceutical Industries Ltd. over Teva's generic version of the acid reflux drug PREVACID® SOLU-TABs™. Sutherland was mentioned for representing Teva. John North and Jeff Toney were lead trial counsel for Teva.

Our Story

Sutherland Asbill & Brennan LLP is an international law firm helping the Fortune 100, industry leaders, sector innovators and business entrepreneurs solve their biggest challenges and reach their business goals. Dedicated to unfaltering excellence in client service, we are known for our business savvy and industry intelligence, providing creative and custom solutions for each of our clients. Industry and business experience makes the difference for our clients.

click to watch Videocast: DOL Fiduciary Rule Litigation Impacts
Videocast: DOL Fiduciary Rule Litigation Impacts
Atlanta, GA
Washington, DC
© 2016 Sutherland Asbill & Brennan LLP / Sutherland (Europe) LLP
MYBRIEFCASE
Add this page to MYBRIEFCASE
Add Page to MYBRIEFCASE
News/Commentary - "Fed. Circ. Deals Blow To Takeda In Prevacid Battle"
Current MYBRIEFCASE Pages
Save ChangesDownload MYBRIEFCASEClear All